Regarding "The safety, efficacy and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions".
Manfredini
Roberto
R
Boari
Benedetta
B
Gallerani
Massimo
M
Portaluppi
Francesco
F
Mehta
Rajendra H
RH
D002406:Catheterization, Peripheral; D006801:Humans; D010960:Plasminogen Activators / Q000191:economics / Q000627:therapeutic use*; D015912:Thrombolytic Therapy / Q000191:economics / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000191:economics / Q000627:therapeutic use*; D016896:Treatment Outcome; D014568:Urokinase-Type Plasminogen Activator / Q000191:economics / Q000627:therapeutic use; D014652:Vascular Diseases / Q000188:drug therapy / Q000191:economics
D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator